Leadership & Pay ·
Tonix Pharmaceuticals Holding Corp. announced on September 8, 2026, the promotion of Thomas Englese to Chief…
TNXPTonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp. announced on September 8, 2026, the promotion of Thomas Englese to Chief Commercial Officer, effective immediately. Mr. Englese previously served as Executive Vice President, Commercial Operations since September 2024 and will continue directing sales, marketing, market access, and commercial operations for TONMYA (cyclobenzaprine HCl sublingual tablets) for fibromyalgia, as well as Zembrace SymTouch and Tosymra for acute migraine. Tonix Pharmaceuticals Holding Corp. is a fully integrated, commercial-stage biopharmaceutical company focused on central nervous system disorders, infectious diseases, and immunology conditions.